Florida controlled-substance agreements, documented contract by contract

Status: Florida evidence build reviewed through October 4, 2026. This library is for Florida patients, clinicians, attorneys, journalists, and researchers who need to distinguish what Florida actually requires from what an individual practice adds.

Florida’s current legal baseline

Florida Statute §456.44 requires a written controlled-substance agreement when a registered prescriber treats chronic nonmalignant pain with Schedule II, III, or IV controlled substances within the statute’s scope. Florida does not prescribe one statewide form, but it does identify subjects the written agreement must address.

State requirement What Florida requires
Prescription/refill terms The agreement must address the number and frequency of controlled-substance prescriptions and refills.
Compliance/discontinuation The agreement must address patient compliance and reasons controlled-substance therapy may be discontinued.
Single treating registrant The agreement must state that controlled substances for chronic nonmalignant pain will be prescribed by one treating registrant unless another prescriber is authorized and documented.
Ongoing visits/monitoring The patient must be seen at intervals not exceeding three months for treatment-plan, efficacy, adherence, and continued-need review.
Risk monitoring A written risk-assessment plan is required; patient drug testing may be part of that plan.
Diversion When the statutory evidence or behavioral indications of diversion are present, the law directs discontinuation of controlled-substance therapy and discharge, with documentation.

Profession-specific overlay: Florida’s osteopathic chronic-pain rule adds its own drug-testing requirements, including testing before initial controlled-substance issuance and random testing at least twice yearly. That rule applies to the profession governed by that rule and should not be generalized to every Florida prescriber.

Recovered Florida agreement dossiers

Current Florida agreement records with a text gap

What changes from one Florida agreement to another

Example condition Verified example How to read it
No THC, marijuana, CBD, including medical use Pain Consultants of West Florida Clinic treatment condition. Florida separately authorizes qualifying medical-marijuana use under §381.986.
Lockbox required for opioid medication Pain Consultants of West Florida Clinic storage policy, not one of §456.44’s minimum agreement subjects.
Smoking cessation, weight-loss program, or physical therapy conditions Florida Spine & Pain Center Clinic treatment-plan conditions, not universal Florida agreement terms.
Return every 28–31 days for 30-day prescriptions The Pain Management Institute Practice prescribing cadence; Florida’s statute requires follow-up at intervals no longer than three months.
Same-day pill count Ramos Center Clinic monitoring implementation. Florida permits drug testing and requires monitoring, but does not impose this same-day rule statewide.
Controlled-substance therapy can stop across the facility after noncompliance Ramos Center Clinic/institutional consequence broader than the state’s minimum contract language.

Medical marijuana: law versus clinic policy

Florida has a statutory medical-marijuana framework under §381.986. Several pain agreements prohibit marijuana or use older controlled-substance terminology. A practice may impose a clinical treatment condition concerning marijuana, but this library does not convert that condition into a claim that all medically authorized marijuana use is unlawful in Florida.

If your Florida agreement is missing

Use the Florida Contract for Care submission guide. Blank copies are best. Preserve the complete form, any revision date, testing/refill policies, and addenda.

Primary Florida authorities

Evidence boundary: Florida’s requirement to use a written agreement does not make every clause inserted by an individual practice a state mandate. Each material term is classified against its own authority.